Cancer Research Horizons
John Taylor is currently serving as a Group Leader - Medicinal Chemistry at Cancer Research Horizons since April 2022. Prior to this, John had roles at Cancer Research UK Beatson Institute as a Staff Scientist, Principal Scientific Officer, and Medicinal Chemistry Senior Scientist. With experience in companies like Syngenta, Eli Lilly and Company, and Evotec, John has a strong background in research chemistry, project leadership, and team management. John holds an MSci in Chemistry from the University of Strathclyde.
This person is not in any teams
Cancer Research Horizons
Cancer Research Horizons is Cancer Research UK's innovation engine. We take scientific breakthroughs from the lab bench to the bedside, translating them into effective treatments and diagnostics for cancer patients. To date, we’ve played an instrumental role in forming over 60 spin-out companies and bringing 11 new cancer drugs to market, borne out of our pioneering research. We are the second biggest licensor of cancer research treatments globally and are part of Cancer Research UK – the world’s largest medical research charity. With exclusive rights to over £300m of world-class cancer research we’re a unique and powerful partner in the fight to beat cancer. We work closely with academia and industry to bridge the gap between research and the market, delivering maximum impact for patients. Every penny we make goes back into developing the next breakthroughs, helping bring forward the day when all cancer is conquered.